Magrolimab: Launch Concept
Role: CD/Copywriter
Magrolimab is a first in class targeted therapy for MDS & AML patients, that blocks CD47 to unmask cancer cells the immune system isn’t able to detect on its own. It’s like having signs to show the immune system the way.
Breyanzi CAR-T: Launch Concept
Role: Copywriter
Breyanzi is the only CAR-T therapy for DLBCL patients that delivers on all the promises of this cutting edge treatment, with much less risk of adverse events. This concept highlighted safety and efficacy for hematologists & oncoligists.
Abecma CAR-T: Launch & Unbranded Concepts
Role: Copywriter
Abecma is the first CAR-T therapy available for Multiple Myeloma patients, and as such it promises to revolutionize treatment protocols and outcomes alike. The following are concepts for a launch and unbranded campaign aimed at HCPs. Pardon the art direction….
Launch
Unbranded